• All sections
  • A - Human necessities
  • A61K - Preparations for medical, dental or toiletry purposes
  • A61K 47/68 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment

Patent holdings for IPC class A61K 47/68

Total number of patents in this class: 14248

10-year publication summary

570
997
1224
1208
1429
1489
1578
1714
1834
1109
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Regeneron Pharmaceuticals, Inc.
4698
247
SeaGen Inc
533
241
Daiichi Sankyo Company, Limited
1893
232
Genentech, Inc.
4099
204
Hanmi Pharm. Co., Ltd.
601
157
Dyne Therapeutics, Inc.
259
149
MedImmune Limited
610
143
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
383
126
ImmunoGen, Inc.
379
125
The Regents of the University of California
20720
122
Bristol-myers Squibb Company
4729
107
Novartis AG
10263
92
Bolt Biotherapeutics, Inc.
113
87
Shanghai Hengrui Pharmaceutical Co., Ltd.
712
75
Sanofi
4293
71
Hoffmann-La Roche Inc.
3783
70
Pfizer Inc.
3384
70
Memorial Sloan-Kettering Cancer Center
2038
70
Genmab A/S
473
70
Zymeworks Inc.
253
69
Other owners 11721